TJXAugust 19, 2026 at 11:30 AM UTCConsumer Discretionary Distribution & Retail

TJX Q2 comp +4% beats guide, margin and EPS above plan; raises FY27 guidance

Read source article

What happened

TJX reported Q2 FY27 net sales of $15.2 billion, up 5%, with consolidated comparable sales up 4%, exceeding its own guidance of +2-3% and clearing the 3% threshold that would have strengthened our bull case. Pretax profit margin and diluted EPS both came in well above plan, and the company raised its full-year FY27 pretax margin and EPS guidance, signaling confidence in margin resilience despite prior tariff and fuel headwinds. The result directly addresses our key near-term checkpoint: whether Q1's 6% comp and 12.0% pretax margin were durable or merely aided by favorable hedge marks; Q2's sustained beat suggests the underlying demand is real. However, we still lack color on whether growth was driven by transactions or basket, and the company's ~$490 million in IEEPA-related tariff payments with no refund receivable remains an overhang. At a stock price around $152, the valuation is still not cheap at roughly 29x earnings, so while the narrative has improved, the margin of safety remains thin.

Implication

For existing holders, the Q2 report validates the business's ability to sustain comp growth above 3% and protect margins, supporting a higher fair value estimate near $168. However, new investors should exercise patience: the stock's 29x P/E already prices in continued strength, and any disappointment in holiday season guidance or margin erosion from tariffs/fuel could trigger multiple compression. We would look to add on any pullback toward $140, which offers a more favorable risk/reward, while a break above $165 without further fundamental improvement would argue for trimming. The key monitoring points are transaction growth in upcoming disclosures, management's commentary on merchandise availability, and any recognition of tariff refunds. Overall, the thesis has strengthened, but the market is likely to reward the news quickly, so chasing the stock here is not advisable.

Thesis delta

The prior WAIT rating was based on uncertainty about whether Q1's strong comp and margin were sustainable. Q2's 4% comp, well above the +2-3% guide, and the increase in FY27 margin/EPS guidance shift the probability toward the bull scenario, where comps stay above 4% and margins hold near 12%. However, the stock's valuation at ~29x earnings still offers limited margin of safety, and we need confirmation that growth is traffic-led and that margin improvements are not from transient factors. Therefore, we upgrade our conviction from 3.5 to 4.0 and move to a more constructive stance, but maintain a WAIT rating pending better entry or further evidence.

Confidence

high